Fine Foods & Pharmaceuticals N.T.M. S.p.A. (FF.MI)

EUR 7.26

(1.68%)

Total Liabilities Summary of Fine Foods & Pharmaceuticals N.T.M. S.p.A.

Fine Foods & Pharmaceuticals N.T.M. S.p.A.'s latest annual total liabilities in 2023 was 114.61 Million EUR , down -31.18% from previous year.
Fine Foods & Pharmaceuticals N.T.M. S.p.A.'s latest quarterly total liabilities in 2024 Q2 was 111.4 Million EUR , up 0.05% from previous quarter.
Fine Foods & Pharmaceuticals N.T.M. S.p.A. reported annual total liabilities of 166.53 Million EUR in 2022, up 7.03% from previous year.
Fine Foods & Pharmaceuticals N.T.M. S.p.A. reported annual total liabilities of 155.59 Million EUR in 2021, up 134.22% from previous year.
Fine Foods & Pharmaceuticals N.T.M. S.p.A. reported quarterly total liabilities of 111.34 Million EUR for 2024 Q1, down -2.85% from previous quarter.
Fine Foods & Pharmaceuticals N.T.M. S.p.A. reported quarterly total liabilities of 114.61 Million EUR for 2023 Q4, down -20.31% from previous quarter.

Annual Total Liabilities Chart of Fine Foods & Pharmaceuticals N.T.M. S.p.A. (2023 - 2016)

Historical Annual Total Liabilities of Fine Foods & Pharmaceuticals N.T.M. S.p.A. (2023 - 2016)

Year	Total Liabilities	Total Liabilities Growth
2023	114.61 Million EUR	-31.18%
2022	166.53 Million EUR	7.03%
2021	155.59 Million EUR	134.22%
2020	66.43 Million EUR	14.32%
2019	58.1 Million EUR	0.73%
2018	57.68 Million EUR	35948.64%
2017	160.02 Thousand EUR	41.39%
2016	113.17 Thousand EUR	0.0%

Year	Total Liabilities	Total Liabilities Growth
2024 Q2	111.4 Million EUR	0.05%
2024 Q1	111.34 Million EUR	-2.85%
2023 Q4	114.61 Million EUR	-20.31%
2023 FY	114.61 Million EUR	-31.18%
2023 Q2	162.8 Million EUR	-7.72%
2023 Q1	176.42 Million EUR	5.94%
2023 Q3	143.82 Million EUR	-11.66%
2022 Q2	181.39 Million EUR	-1.29%
2022 Q4	166.53 Million EUR	-2.22%
2022 FY	166.53 Million EUR	7.03%
2022 Q1	183.76 Million EUR	18.11%
2022 Q3	170.31 Million EUR	-6.11%
2021 Q1	- EUR	-100.0%
2021 FY	155.59 Million EUR	134.22%
2021 Q4	155.59 Million EUR	68.63%
2021 Q3	92.26 Million EUR	-2.38%
2021 Q2	94.52 Million EUR	0.0%
2020 Q2	66.22 Million EUR	0.0%
2020 Q1	66.22 Million EUR	13.97%
2020 FY	66.43 Million EUR	14.32%
2020 Q4	66.43 Million EUR	0.0%
2019 FY	58.1 Million EUR	0.73%
2019 Q3	78.87 Million EUR	15.65%
2019 Q1	68.2 Million EUR	18.23%
2019 Q2	68.2 Million EUR	-0.0%
2019 Q4	58.1 Million EUR	-26.33%
2018 Q1	- EUR	-100.0%
2018 FY	57.68 Million EUR	35948.64%
2018 Q3	57.68 Million EUR	10155.59%
2018 Q2	562.47 Thousand EUR	0.0%
2018 Q4	57.68 Million EUR	0.0%
2017 Q4	160.02 Thousand EUR	0.0%
2017 Q2	56.12 Thousand EUR	0.0%
2017 FY	160.02 Thousand EUR	41.39%
2016 FY	113.17 Thousand EUR	0.0%

Peer Total Liabilities Comparison of Fine Foods & Pharmaceuticals N.T.M. S.p.A.

Name	Total Liabilities	Total Liabilities Difference
Centrale del Latte d'Italia S.p.A.	184.82 Million EUR	37.99%
Valsoia S.p.A.	38.88 Million EUR	-194.739%